Table 4.
Development of CT, CFT, AA, and MCF values in INTEM in high-risk patients during pregnancy, after the postpartum period, and in the control group. Data are presented in the form of medians and interquartile ranges.
| Variable | Co | T1 | T2 | T3 | T4 | T5 |
|---|---|---|---|---|---|---|
| CT | 173 (158, 184) | 186 (174, 220) | 162 (157, 210) | 163(144, 176) | 157 (151, 171) | 177 (163, 181) |
| CFT | 73 (64, 83) | 88 (73, 111) * | 70 (64, 75) | 66 (52, 72) | 58 (54, 68) ** | 68 (63, 79) |
| AA | 75.0 (74.0, 77.0) | 72.0 (68.0, 75.2) | 76.5 (75.0, 77.2) | 77.0 (75.5, 79.0) | 78.0 (77.0, 79.0) ** | 76.0 (74.0, 77.2) |
| MCF | 60.0 (58.0, 63.0) | 61.5 (57.8, 63.2) | 64.5 (60.5, 66.2) | 67.0 (64.0, 70.0) *** | 68.0 (65.0, 71.0) *** | 61.5 (59.8, 64.5) |
Legend: AA—alpha angle, CFT—clot formation time, Co—control group, CT—clotting time, MCF—maximum clot firmness, T1—time interval 1, T2—time interval 2, T3—time interval 3, T4—time interval 4, T5—time interval 5. Significant differences of the results between T1–T5 and controls are highlighted with asterisk sign according to the following key: * <0.05, ** <0.01 and *** <0.001. p-values are related to ANOVA test.